At a business briefing, Tokuyama Corporation indicated that it would focus on expanding the in vitro diagnostics market. Against a backdrop of rising healthcare costs due to population aging and advances in medical care, the company outlined its expectations for growing demand for testing.
At a business briefing held on the 30th, Tokuyama Corporation outlined its policy of focusing on and expanding the in vitro diagnostics market.
The backdrop includes rising healthcare costs due to population aging and advances in medical care, and the company explained that it expects demand for testing to grow.
The company is advancing the expansion of its IVD business and is considering broadening its lineup of related products, according to reports.